ArticleVirology journal2026
Dengue virus genetic diversity and lineage dynamics in Thailand: implications for surveillance and vaccine implementation.
Article in Virology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDengue fever, caused by dengue virus (DENV), is a major public health problem in tropical and subtropical regions. Thailand is considered endemic for dengue, and all four DENV serotypes co-circulate in this country. Monitoring the genetic diversity of DENV is important for establishing local control policies.
methodsThis study sequenced the complete envelope gene from 92 DENV isolates collected at the Hospital for Tropical Diseases between October 2023 and September 2024. These sequences were analyzed together with dengue virus sequences circulating in Thailand between 2000 and 2024, retrieved from the National Center for Biotechnology Information (NCBI) virus database. The DENV sequences were evaluated for lineage determination and phylogenetic analysis.
resultsOur findings identify the presence or introduction of dengue genotypes in the endemic area. The results revealed the co-circulation of all four DENV serotypes, and DENV-2 was the dominant serotype (44.57%). The predominant serotype switched in response to dengue outbreaks throughout the study period. Phylogenetic analysis revealed that DENV-1 sequences belonged to genotype I, whereas DENV-2 sequences belonged to genotype II and V. Moreover, the dengue vaccine strain was identified via sequencing (Thailand 2024). DENV-3 genotype III was the major circulating genotype from 2013 to 2024. Meanwhile, DENV-4 isolates belonged to genotype I, lineage A.3. In addition, the substitution of the dominant lineage was associated with dengue epidemics.
conclusionsThe co-circulation of all four DENV serotypes has been exhibited in Thailand. Dengue vaccine implementation is both affected by existing DENV circulation and can influence future DENV circulation within a population. Understanding DENV evolution, genotype replacement, and multiple-virus lineage circulation is vital for enhancing surveillance, responding to DENV epidemics, and implementing vaccination programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.